chr3-183825243-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_024871.4(MAP6D1):c.305C>T(p.Ala102Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,382,718 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A102T) has been classified as Benign.
Frequency
Consequence
NM_024871.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAP6D1 | NM_024871.4 | c.305C>T | p.Ala102Val | missense_variant | 1/3 | ENST00000318631.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAP6D1 | ENST00000318631.8 | c.305C>T | p.Ala102Val | missense_variant | 1/3 | 1 | NM_024871.4 | P1 | |
MAP6D1 | ENST00000431348.1 | c.305C>T | p.Ala102Val | missense_variant | 1/3 | 2 | |||
MAP6D1 | ENST00000445426.1 | c.281C>T | p.Ala94Val | missense_variant, NMD_transcript_variant | 1/3 | 4 | |||
MAP6D1 | ENST00000463801.1 | upstream_gene_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000316 AC: 48AN: 152016Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00241 AC: 56AN: 23208Hom.: 1 AF XY: 0.00175 AC XY: 23AN XY: 13136
GnomAD4 exome AF: 0.0000894 AC: 110AN: 1230594Hom.: 3 Cov.: 30 AF XY: 0.0000834 AC XY: 50AN XY: 599590
GnomAD4 genome AF: 0.000322 AC: 49AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.000323 AC XY: 24AN XY: 74390
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at